nference is a biomedical technology that is building a holistic software platform that synthesizes the world’s exponentially-growing unstructured, semi-structured, and structured biomedical knowledge bases using state-of-the-art neural networks.
Powered by its Augmented Intelligence software platform, the nference mission is to synthesize the world’s exponentially growing biomedical knowledge.
nference was founded in 2015 by Murali Aravamudan and Venky Soundararajan. The company is headquartered in Cambridge, Massachusetts, with offices in Toronto, Ontario and Bangalore, Karnataka, India.
nference uses state-of-the-art neural networks (shallow and deep learning models) for real-time, automated extraction of insights from the scientific, clinical, regulatory and commercial data sets. The platform enables a diverse set of applications ranging from R&D to commercial strategy and operations in the life sciences ecosystem.
nference is making biomedical knowledge computable, and building its AI platform to serve as the connective fabric for various silos of information that exist in unstructured, semi-structured, and structured forms across health care enterprises.
nference is backed by Matrix Partners, Matrix Capital Management, Mayo Clinic Ventures, and NTT Venture Capital. The company raised $60M in a Series B financing on Jan 08, 2020. This new round brings nference's total funding $74M to date.